Therapeutic vaccination with 4–1BB co-stimulation eradicates mouse acute myeloid leukemia

Medicine and Dentistry

• Acute Myeloid Leukemia 100%
• Co-Stimulation 100%
• Neoplasm 66%
• Natural Killer T Cell 50%
• Disease 33%
• Combination Therapy 33%
• Cytotoxic T-Cell 33%
• Lymphoid Leukemia 33%
• Tumor Progression 16%
• Hematologic Malignancy 16%
• Tumor Cell 16%
• Immunity 16%
• Host Cell 16%
• Treatment Response 16%
• Immunotherapy 16%
• Alpha Galactosylceramide 16%

Immunology and Microbiology

• Co-Stimulation 100%
• Myeloid 100%
• Natural Killer T Cell 50%
• Cytotoxic T-Cell 33%
• Immunology 33%
• Immunity 16%
• Tumor Cell 16%
• Solution and Solubility 16%
• Host Cell 16%
• Immunotherapy 16%
• T-Cell Vaccination 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Myeloid Leukemia 100%
• Neoplasm 83%
• CD8 Antigen 33%
• Disease 33%
• Combination Therapy 33%
• Lymphatic Leukemia 33%
• Hematologic Malignancy 16%
• Tumor Growth 16%
• Immunotherapy 16%
• Alpha Galactosylceramide 16%